Chemoprevention of prostate cancer in men at high risk: Rationale and design of the reduction by dutasteride of prostate cancer events (reduce) trial

Gerald Andriole, David Bostwick, Otis Brawley, Leonard Gomella, Michael Marberger, Donald Tindall, Sharon Breed, Matt Somerville, Roger Rittmaster

Research output: Contribution to journalArticlepeer-review

258 Scopus citations

Fingerprint

Dive into the research topics of 'Chemoprevention of prostate cancer in men at high risk: Rationale and design of the reduction by dutasteride of prostate cancer events (reduce) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences